These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10856466)

  • 21. Fertilization and embryo development with spermatozoa obtained from testicular sperm extraction into oocytes generated from human chorionic gonadotropin-primed in vitro maturation cycles.
    Son WY; Chung JT; Henderson S; Reinblatt S; Buckett W; Chan PT; Holzer H
    Fertil Steril; 2013 Oct; 100(4):989-93. PubMed ID: 23806848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection.
    Takeuchi S; Minoura H; Shibahara T; Tsuiki Y; Noritaka F; Toyoda N
    Fertil Steril; 2001 Sep; 76(3):532-7. PubMed ID: 11532477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes and development of children born after intracytoplasmic sperm injection (ICSI) using extracted testicular sperm or ejaculated extreme severe oligo-astheno-teratozoospermia sperm: a comparative study.
    Tsai CC; Huang FJ; Wang LJ; Lin YJ; Kung FT; Hsieh CH; Lan KC
    Fertil Steril; 2011 Sep; 96(3):567-71. PubMed ID: 21880275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins.
    Marci R; Senn A; Dessole S; Chanson A; Loumaye E; De Grandi P; Germond M
    Fertil Steril; 2001 Jun; 75(6):1131-5. PubMed ID: 11384638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
    Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Falling estradiol levels on day after human chorionic gonadotropin administration in assisted reproductive technology cycles are not predictive of decreasing oocyte maturity or pregnancy rates.
    Levy G; Hill M; Beall S; Pilgrim JD; Payson M; Propst A
    J Reprod Med; 2014; 59(5-6):255-9. PubMed ID: 24937966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of triploid zygotes on intracytoplasmic sperm injection outcomes.
    Figueira RC; Setti AS; Braga DP; Iaconelli A; Borges E
    J Assist Reprod Genet; 2011 Sep; 28(10):879-83. PubMed ID: 21805146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization.
    Walls ML; Hart R; Keelan JA; Ryan JP
    Fertil Steril; 2016 Nov; 106(6):1392-1398.e5. PubMed ID: 27565256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fertilization, embryo development, and clinical outcome of immature oocytes from stimulated intracytoplasmic sperm injection cycles.
    Shu Y; Gebhardt J; Watt J; Lyon J; Dasig D; Behr B
    Fertil Steril; 2007 May; 87(5):1022-7. PubMed ID: 17261289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Peak Estradiol/Mature Oocyte Ratio Predicts Lower Clinical Pregnancy, Ongoing Pregnancy, and Live Birth Rates in GnRH Antagonist Intracytoplasmic Sperm Injection Cycles.
    Sandoval JS; Steward RG; Chen C; Li YJ; Price TM; Muasher SJ
    J Reprod Med; 2016; 61(1-2):11-6. PubMed ID: 26995882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
    Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
    Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birth after the injection of sperm and the cytoplasm of tripronucleate zygotes into metaphase II oocytes in patients with repeated implantation failure after assisted fertilization procedures.
    Huang CC; Cheng TC; Chang HH; Chang CC; Chen CI; Liu J; Lee MS
    Fertil Steril; 1999 Oct; 72(4):702-6. PubMed ID: 10521114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of delaying hCG administration to enable maturation of medium-sized follicles in patients undergoing superovulation for IVF/ICSI.
    Awonuga AO; Wheeler K; Thakur M; Jeelani R; Diamond MP; Puscheck EE
    J Assist Reprod Genet; 2018 Feb; 35(2):289-295. PubMed ID: 28965278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of oocyte cryopreservation on embryo development.
    Magli MC; Lappi M; Ferraretti AP; Capoti A; Ruberti A; Gianaroli L
    Fertil Steril; 2010 Feb; 93(2):510-6. PubMed ID: 19342025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K; Kogan I; Krikheli I; Dzhemlikhanova L; Muller V; Mekina I; Lesik E; Komarova E; Mazilina M; Niauri D; Gzgzyan A; Aylamazyan E
    Gynecol Endocrinol; 2017; 33(sup1):15-17. PubMed ID: 29264990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
    Sahu B; Ozturk O; Ranierri M; Serhal P
    Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.